IBJNews

BioCrossroads seeds upstart medical device maker

Back to TopCommentsE-mailPrintBookmark and Share

BioCrossroads’ Indiana Seed Fund has invested $300,000 in a startup company developing an absorbable stent to treat cardiovascular disease.

Zorion Medical is chaired by former Eli Lilly and Co. executive David Broecker, who has relocated to Indianapolis from Boston. Broecker, a Wabash College graduate in chemistry and mathematics, previously was president and CEO of Cambridge, Mass.-based biopharmaceutical company Alkermes Inc.

Broecker also is CEO of BioCritica Inc., a locally-based firm founded last May that acquired commercialization rights to Lilly’s Xigris, a drug to treat the blood infection sepsis.

The BioCrossroads investment in Zorion will help fund further proof-of-concept work, including another pre-clinical study Zorion plans in the first quarter of 2012 involving animals.

The company developed a stent that can be absorbed into the body—essentially to disappear.

The biomaterial also can deliver drugs to help heal the artery.

Stents—mesh-like tubes—are implanted to prop open narrowed arteries. Traditionally they’ve been made from metal and designed to be a permanent fixture in the artery. The downside is that clotting may occur, requiring patients to take blood thinners.

Medical device companies have been developing stents that can be absorbed into an artery. Most of these, including one recently launched by Abbott Laboratories, are made of a polymer material and take up to two years to disappear in the body.

Zorion’s stent is made of a metal-like substance that is said to disappear in only three to six months. Broecker has likened Zorion’s product to a splint rather than a stent.

Another potential market advantage of Zorion’s metallic-based absorbable material is that cardiologists are already familiar with the properties of metal stents.

“We hope to be a fast follower” to polymer stents, said Broecker.

“Fast” is relative in the highly regulated medical device industry. Broecker said a market launch in five years is probably a safe bet. A partnership with an established player in the cardiology market is a possibility.

In the meantime, the upstart has been operating much as a virtual company, with its handful of employees scattered as far as Europe.

Broecker said he is hopeful of building jobs in the Indianapolis area as stent development and testing progresses.

Metal and drug-eluting stents are a $6 billion market globally.

“It’s obviously an enormous market and this is very disruptive technology,” said David Johnson, president and CEO of BioCrossroads, saying Zorion’s approach has the potential to be a “tremendous breakthrough technology.”

The $6 million Indiana Seed Fund was launched in 2005.  Zorion represents its 12th investment.

Periculum Capital, an Indianapolis-based private investment and merchant banking group, also made an undisclosed investment in Zorion, Biocrossroads said.

BioCrossroads is the state's initiative to grow the life sciences industry.

ADVERTISEMENT

Post a comment to this story

COMMENTS POLICY
We reserve the right to remove any post that we feel is obscene, profane, vulgar, racist, sexually explicit, abusive, or hateful.
 
You are legally responsible for what you post and your anonymity is not guaranteed.
 
Posts that insult, defame, threaten, harass or abuse other readers or people mentioned in IBJ editorial content are also subject to removal. Please respect the privacy of individuals and refrain from posting personal information.
 
No solicitations, spamming or advertisements are allowed. Readers may post links to other informational websites that are relevant to the topic at hand, but please do not link to objectionable material.
 
We may remove messages that are unrelated to the topic, encourage illegal activity, use all capital letters or are unreadable.
 

Messages that are flagged by readers as objectionable will be reviewed and may or may not be removed. Please do not flag a post simply because you disagree with it.

Sponsored by
ADVERTISEMENT

facebook - twitter on Facebook & Twitter

Follow on TwitterFollow IBJ on Facebook:
Follow on TwitterFollow IBJ's Tweets on these topics:
 
Subscribe to IBJ
  1. These liberals are out of control. They want to drive our economy into the ground and double and triple our electric bills. Sierra Club, stay out of Indy!

  2. These activist liberal judges have gotten out of control. Thankfully we have a sensible supreme court that overturns their absurd rulings!

  3. Maybe they shouldn't be throwing money at the IRL or whatever they call it now. Probably should save that money for actual operations.

  4. For you central Indiana folks that don't know what a good pizza is, Aurelio's will take care of that. There are some good pizza places in central Indiana but nothing like this!!!

  5. I am troubled with this whole string of comments as I am not sure anyone pointed out that many of the "high paying" positions have been eliminated identified by asterisks as of fiscal year 2012. That indicates to me that the hospitals are making responsible yet difficult decisions and eliminating heavy paying positions. To make this more problematic, we have created a society of "entitlement" where individuals believe they should receive free services at no cost to them. I have yet to get a house repair done at no cost nor have I taken my car that is out of warranty for repair for free repair expecting the government to pay for it even though it is the second largest investment one makes in their life besides purchasing a home. Yet, we continue to hear verbal and aggressive abuse from the consumer who expects free services and have to reward them as a result of HCAHPS surveys which we have no influence over as it is 3rd party required by CMS. Peel the onion and get to the root of the problem...you will find that society has created the problem and our current political landscape and not the people who were fortunate to lead healthcare in the right direction before becoming distorted. As a side note, I had a friend sit in an ED in Canada for nearly two days prior to being evaluated and then finally...3 months later got a CT of the head. You pay for what you get...

ADVERTISEMENT